Trypanosoma cruzi antigenic specificities involved in human T-celi and antibody responses were compared in chronic chagasic patients affected with cardiomyopathy (C) or with the indeterminate form (I), the asymptomatic form of chronic Chagas' disease. T-cell Western blotting (immunoblotting) was performed to identify the most active antigens in epimastigote extracts (EPI-Ag). The patterns of peripheral blood mononuclear cell (PBMC) and T-cell proliferative responses induced by fractions blotted to nitrocellulose were heterogeneous, but the computation of their frequency distribution disclosed some important antigen specificities. Molecules ranging from 100 to 150 kilodaltons (kDa) were frequently stimulatory to PBMC from I patients (5 of 8 cases) and were less so when confronted with C patient (1 of 7 cases) lymphocytes. In contrast, both groups of patients actively responded to fractions ranging from 48 to 57 and 28 to 32 kilodaltons (kDa). The Western immunoblotting patterns of antibody reactivity displayed by 17 C and 15 I patients were also similar, yielding outstanding staining in the molecular mass ranges of 70 to 80 and 43 to 57 kDa. The latter antigen complex was recognized by 100% of the 32 chronic Chagas' disease serum specimens tested and closely corresponded to the migratory position recognized by T cells of most patients tested. The identification of the active molecules contained in the 43-to 57-kDa region was sought, with a focus on GP57/51, an antigen with well-established serodiagnostic properties. Immunoblotting analysis of EPI-Ag with a monoclonal antibody to GP57/51 confirmed its presence within the predicted molecular weight region. Highly purified GP51 was then used to demonstrate directly its capacity to promote specffic PBMC proliferative responses in vitro. Data computed from a survey with 12 patients have shown a linear correlation (r = 0.93) between PBMC responses to EPI-Ag and to purified GP51, suggesting that the immune response to this particular glycoprotein may be an important component of human immune responses against T. cruzi.
similar, yielding outstanding staining in the molecular mass ranges of 70 to 80 and 43 to 57 kDa. The latter antigen complex was recognized by 100% of the 32 chronic Chagas' disease serum specimens tested and closely corresponded to the migratory position recognized by T cells of most patients tested. The identification of the active molecules contained in the 43-to 57-kDa region was sought, with a focus on GP57/51, an antigen with well-established serodiagnostic properties. Immunoblotting analysis of EPI-Ag with a monoclonal antibody to GP57/51 confirmed its presence within the predicted molecular weight region. Highly purified GP51 was then used to demonstrate directly its capacity to promote specffic PBMC proliferative responses in vitro. Data computed from a survey with 12 patients have shown a linear correlation (r = 0.93) between PBMC responses to EPI-Ag and to purified GP51, suggesting that the immune response to this particular glycoprotein may be an important component of human immune responses against T. cruzi.
Chagas' disease is caused by parasitic infection with the protozoan Trypanosoma cruzi. In human hosts, a wide clinical spectrum of disease is observed, ranging from the indeterminate form, in which morbidity is apparently absent upon superficial clinical examination methods, to severe heart disease leading to heart failure and sudden death. Also, a small percentage of infected patients display the digestive form of the disease, characterized by pathological dilatations of the digestive tract (5) . Chagasic megasyndromes appear to result from pathological denervation of nervous plexuses of hollow organs such as the colon or esophagus (14) . A significant proportion of the chagasic population eventually develops the severe manifestations of chronic disease (Z. Brener and A. U. Krettli, in D. J. Wyler, ed., Modern Parasite Biology: Cellular, Molecular and Immunology Aspects, in press), but the factors determining this susceptibility are unknown. The biological heterogeneity of T. cruzi strains (4, 13, 28) and host characteristics such as human lymphocyte antigen phenotype (16) may conceivably contribute to the varied clinical expressions of chronic Chagas' disease (CCD).
The pathogenic mechanisms underlying chronic chagasic myocarditis are still undefined. Mononuclear cell infiltrates are typically focal but are widely distributed in the myocar-* Corresponding authors. dium; cardiac muscle destruction is followed by progressive fibrous replacement of the myocardium. Interestingly, intracellular parasites are hardly found in histological sections (2) . This latter observation, together with the prolonged asymptomatic period of the disease, has been taken to suggest an autoimmune basis for chronic chagasic pathology (8, 9) . Some evidence in favor of this hypothesis has come from in vitro studies describing self-reactive lymphocytes (1, 8, 12) ; cross-reactivity between epimastigote T. cruzi antigens and mammalian structures have been also described with chagasic sera and monoclonal antibodies (MAb) (27, 36, 40) , but their role in heart and digestive system pathology has not been assessed. In spite of the persisting controversy about the reliability of the proposed animal models for CCD (6) , it has been generally agreed that the chronic inflammatory process is driven by T cells (12, 33) . Whether or not directed to cross-reactive molecular species, there is a need to assess the T. cruzi antigens which stimulate T-cell responses in patients affected with the various clinical forms of CCD. Intense T-cell proliferation responses have been previously reported with the majority (75%) of chagasic patients tested with epimastigote antigens (EPI-Ag) (23) . In the present study, we have used the technique described by Young and Lamb (17, 41) , referred to as the T-cell Western immunoblot procedure, to examine directly the pattern of human T-cell reactivity against separated EPI-Ag. In paral-1438 GAZZINELLI ET AL. lel, we have performed the standard antibody-developed Western immunoblot analysis (17, 38) against the same crude EPI-Ag to identify highly antigenic parasite proteins in this preparation. This study has drawn attention to a frequently T-cell stimulatory fraction in the molecular mass range of 43 to 57 kiodaltons (kDa), which, in addition, was markedly reactive with serum antibodies. Subsequent characterization of this fraction has led to the identification of GP57/51 (30), an antigen previously described as a highly effective serodiagnostic reagent for Chagas' disease (30, 32) , and now as an important T. cruzi antigen in both cellular and humoral response of chronic chagasic patients.
(Results of this investigation were presented at the 15th
Annual Meeting on Basic Research in Chagas' Disease, Caxambu, Brazil, November 1988.) MATERIALS AND METHODS Study population. The patients (not submitted to chemotherapy) included in the current study were chronically infected and originated from different endemic areas of the state of Minas Gerais. The patients had been divided according to a minimum clinical criterion based on physical examination, chest X ray, and electrocardiography into two groups: the indeterminate group, including 17 asymptomatic patients (mean age = 38 ± 16), and 15 patients displaying cardiac disturbances of variable degrees (mean age = 45 + 12). Serodiagnosis was performed by complement fixation, by indirect immunofluorescence tests, and by enzyme-linked immunosorbent assay, prepared with purified GP51 in the solid phase; chagasic patients were seropositive in each test. Six seronegative normal individuals were used as controls. Informed consent was obtained before the inclusion of each subject into the study.
T. cruzi EPI-Ag preparations. Antigens were prepared from the Y strain initially isolated from an acute case of Chagas' disease (35) and thereafter maintained in the laboratory in mice or culture medium or both. The epimastigotes (7) were washed three times in cold phosphate-buffered saline (PBS) (pH 7.0), disrupted by repeated freezing at -20°C and thawing, and homogenized at 4 to 6°C in a Potter-Elvejem centrifuge at 20,000 rpm five times for 60 s, with 30-s intervals on ice. The suspension was subsequently centrifuged at 40,000 x g for 60 min at 4°C. The clear supernatant was dialyzed for 24 h at 4°C against 0.15 M NaCl, filter sterilized on 0.2-pLm membranes, assayed for protein by the Lowry method (19) , and stored at -20°C. This preparation was used for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (16) , and Western blot (38) , T-cell Western blot (17, 41) , peripheral blood mononuclear cells (PBMC), and T-cell proliferation assays (9) . The purified GP51 was isolated from aqueous extracts of epimastigotes as previously described (32) Preparation of immunoblots for cell proliferation assay. The methodology used was first described by Young and Lamb (17, 41) and modified by Melby et al. (21) . EPI-Ag protein (1 mg) was submitted to PAGE as described above. Electrophoresis was carried out until the dye front reached the 12-cm run. The gel was washed three times for 1 h each time with 0.4 liters of transfer buffer (25 (38) , with a constant current of 200 mA for 12 to 16 h. The NC was then handled aseptically and washed in PBS with 100 ,ug of gentamicin per ml for 4 h. Two 0.5-cm wide strips were cut, and one was used for Western blotting and the other for amido black staining to visualize the electrophoretic pattern. The remaining NC paper was overlaid on a 96-well flatbottom tissue culture plate (Linbro; Flow Laboratories). NC discs were then punched into individual wells by using 6-mm skin biopsy punch (Baker-Cummings, Division of Key Pharmaceuticals, Inc., Miami, Fla.) to give 12 triplicate rows. Additional discs of blank NC were punched into wells for the appropriate antigen and phytohemagglutinin controls.
Cell preparations. PBMC were isolated by Ficoll-diatriazoate density gradient centrifugation (LSM; Organon Teknika, Charleston, S.C.) as previously described (22 (10) . Degalon beads (Degalon V26 polymethacrilate beads; Degussa Corp., Teter- boro, N.J.) were irradiated, sterilized, hydrated, and conjugated with affinity purified goat anti-human IgG and IgM (Jackson Immuno Research Laboratories Inc., Avondale, Pa.) (2 mg of antibody per ml per 10 ml of beads); the beads were washed extensively to remove unconjugated antibody and were stored in sterile PBS containing 0.1% sodium azide. NA cells (10 x 106/ml of RPMI) were added to a 10-ml column packed with IgG-conjugated Degalon beads equilibrated with RPMI. The column was eluted at room temperature at a flow rate of 0.5 to 0.7 ml/min. NA cells (T cells) were collected and assayed for antigenic markers by indirect immunofluorescence. A cells (B cells) were collected by repeated washing and continual gentle agitation of the beads and were characterized by immunofluorescence.
Immunofluorescence. Indirect immunofluorescence analysis of T cells used monoclonal anti-T3 (hybridoma cell line CRL-8001; American Type Culture Collection, Rockville, Md.). Monocytes and macrophages were identified with monoclonal B.52.1. jig of Fungizone per ml; GIBCO), and 5% AB Rh', heatinactivated normal human serum. Cultures were made in flat-bottom microwell tissue culture plates and were maintained at 37°C in 5% CO2 in air for 4 to 6 days, as stated. They were exposed to 0.5 ,uCi of tritiated thymidine per culture (specific activity, 17 Ci/mM; Dupont, NEN Research Products, Boston, Mass.) for the last 12 h of culture and processed for scintillation counting (9 uniform, ranging from 95 to 14 kDa, as shown by Coomassie blue staining of SDS-PAGE (Fig. 1A) . A pair of strongly stained bands at the molecular mass range of 40 to 45 kDa was consistently observed in the various batches of EPI-Ag tested. The molecular mass distribution of PBMC reactivity to EPI-Ag antigens was heterogeneous in each one of the two groups of patients; one cardiac (C/191) and two indeterminate (I/131 and I/163) patients did not respond to the blotted or soluble EPI-Ag (data not shown) and could not be distinguished from controls ( Fig. 2; N/l, 2, and 3) . Frequency analysis of the proliferative responses elicited by the various fractions indicated that cardiac chagasic patients (Fig. 3A ) responded more frequently with higher magnitude to fractions 10 to 12 (48 to 57 kDa) and fraction 16 (28 to 32 kDa); the actual levels of these proliferative response values were statistically different from those obtained from fractions 1, 2, 3, 7, 8, and 19 (P < 0.05). Indeterminate patients responded (Fig. 3B ) more actively and frequently to fractions 2 and 3 (100 to 150 kDa), 11 and 12 (48 to 55 kDa), and 16 (28 to 32 kDa), and the proliferative response to these fractions differed statistically (P < 0.05) from fractions 1, 6, 8, 22, 23, and 24. Comparing the response to the same fraction between the two groups, we found that cardiac patients presented a higher response to fractions 9, 10, and 24 (P < 0.05). To check the reproducibility of the assay and the cell population involved in these responses, PBMC and fractionated T cells of three chagasic patients were tested in T-cell Western blotting and the patterns were basically the same. The experiments illustrated in Fig. 4A and B show PBMC and T-cell responses from a single chagasic patient. PBMC response to unfractionated EPI-Ag was 30% suppressed by NC when compared with the response to unfractionated EPI-Ag alone. The NC itself was not mitogenic (Fig. 5) .
Comparison of humoral and cellular responses to electrophoretically separated EPI-Ag. Humoral and cell proliferative responses of individual patients were analyzed with respect to antigen specificity by using the appropriate versions of Western blotting techniques. Representative results, observed with two chagasic patients, are depicted in Fig. 5 . The antibody patterns show that apart from several weakly stained bands observed at 120, 65, 31, and 25 kDa, the presence of two major, but diffuse, antigenic complexes ranging from 70 to 80 and from 43 to 57 kDa were readily distinguished. These two groups of conspicuous bands were recognized by patients' sera regardless of the clinical form of CCD (Fig. 5, patients 143 and 193) . None of the specific antigens were recognized preferentially by sera of patients with one of the clinical forms of Chagas' disease ( Fig. 6A and  B) . Inspection of the T-cell Western immunoblots ( Fig. 2 and  3 ) obtained from most patients revealed that the 70-to 80-kDa antigenic complex was recognized by 80% of chagasic sera tested (Fig. 6) Fig. 2 with responses at the control levels were not included in the means.
57-kDa complex. Interestingly, 100% of the CCD sera tested, independent of the clinical form of the disease, displayed reactivity toward the 43-to 57-kDa antigen complex (Fig. 6) , suggesting that the responses of antibodies to this set of molecules were ubiquitous.
GP51 recognition of CCD T cells and immune sera. Immunoblotting analysis of fractionated EPI-Ag extract with MAb to GP57/51 (Fig. 7, lane 3) revealed the presence of the doublet in the fractions 11 and 12, corresponding in part to the 43-to 57-kDa complex defined with a representative CCD serum (Fig. 7, lane 1) . Direct evidence for the T-cell activating properties of GP57/51 was then sought by using a highly purified (Fig. 1B) GP51 and purified T cells from PBMC of chagasic patients. Figure 8A shown reveal that proliferative responses to GP51 become noticeable at 0.5 ,ug/ml, their mean S.I. slowly increasing up to the 5 pg/ml limit. Responsiveness to crude EPI-Ag was also broadly distributed; in contrast to the mean S.I. values observed with GP51, the response to EPI-Ag showed a steep increase at the upper concentration limit, possibly because threshold levels of minor antigen subcomponents were attained. Interestingly, a direct correlation was found (r = 0.93) between PBMC responses to EPI-Ag and those to purified GP51, both at 5 ,ug/ml (Fig. 8B) . No correlation between EPI-Ag and mitogen T-cell response was observed (data not shown). Finally, Fig. 4C and D shows that in patient 193, the T cells were the responsive cell population, while A cells did not respond to soluble EPI-Ag or GP51. DISCUSSION It has been suggested that humoral and cellular immune responses play a role in the pathogenesis of experimental and human Chagas' disease through an effector or an immunoregulatory mechanism or both (3, 10, 12, 33) . The contribution of specific parasite antigens to host pathology remains to be evaluated. More information has been obtained with respect to protective mechanisms; cumulative evidences implicate immune T cells in protective responses (25, 26) , the role of antibodies and B cells also probably being relevant (15, 37) . These two compartments of the immune system may operate in the control of human infection, thereby limiting parasite burden during the chronic phase. A systematic analysis of T-cell antigen specificities involved in the human response to T. cruzi is mandatory because of inconsistencies found with the animal models proposed for the chronic pathology of the disease (6) . With this aim, we sought to identify T-cell parasite antigens that might be (i) uniquely associated with cardiomyopathy or with asymptomatic CCD and (ii) recognized by a large proportion of patients, that is, highly prevalent specificities possibly associated with acquired resistance. In a recent study, we demonstrated that crude EPI-Ag induce a strong lymphoproliferative responsiveness in the PBMC of chagasic patients (22) ; no relationship was found between the magnitude of response to different specific T. cruzi strains and the clinical form of CCD patients. The analysis of the antigen-specific cellular and humoral responses mounted by these individual patients was the object of the present study. This was achieved by using the technique reported by Young and Lamb (17, 41) less of the clinical expression of CCD. Molecules separating in the molecular mass range of 43 to 57 kDa were of particular interest because they seemed to overlap with a major B-cell antigen, as defined by CCD seroreactivity, as shown here and in previously reported studies, including Western blot (11) as well as immunoprecipitation of native T. cruzi antigens metabolically labeled (20, 29) . The highly visible band staining at this broad region was reminiscent of that observed with antibodies specific for GP57/51, a previously described antigen (32) . Monoclonal antibodies to GP57/51 indeed confirmed its presence within the 43-to 57-kDa (fractions 11 and 12) T-cell stimulatory fractions, the diffuse staining profile obtained by MAb immunoblotting corresponding closely to that observed after treatment with CCD sera. Direct evidence for the T-cell activating properties of this antigen was obtained following PBMC exposure to highly purified GP51. Interestingly, a direct correlation was observed between individual responses against the soluble (crude) EPI-Ag and that against purified GP51, suggesting that the latter specificity might represent an important component of the T-cell repertoire engaged in anti-T. cruzi (EPI-Ag) recognition. It should be pointed out, however, that 3 out of 15 patients did not mount a significant response to any of the blotted fractions. These results are in agreement with observations made by Morato and coworkers (22) , in that the PBMC of 28% of CCD patients did not respond to soluble EPI-Ag, even when exposed to extracts prepared from various T. cruzi strains. Most significantly, however, these patients showed rather high titers of serum IgG responses to soluble EPI-Ag, as well as to purified GP51 (data not shown). It is also pertinent that, within the group of responders, an inverse correlation was often observed between the magnitude of GP51-induced PBMC proliferation and anti-GP57/51 IgG serum titers (data not shown). These findings may merely reflect regulatory fluctuations involving specific B and T cells and/or the engagement of different subsets of T-helper cells in proliferative responses against EPI-Ag and, in particular, against GP57/51. Although there are no dramatic differences in the magnitude of the PBMC response of chagasic patients with the various clinical forms to specific EPI antigens, it is possible that preferential induction of different subsets of T-helper cells by specific antigens of an infectious agent (23) , as it occurs in experimental leishmaniasis (34) , or different stages of the disease or host genetic background may be crucial in the immunoregulation through a production of different lymphokines, with important consequences for both protection and immunopathology of Chagas' disease. Moreover, influences dictated by T-cell pathological immune response in certain patients. In this context, the structural characterization of T-cell epitopes of GP57/51 might be of interest, in the light of the recent demonstration that the antigen is a cysteine proteinase and that it shows extensive N-terminus sequence homologies with human cathepsins L, H, and B (Murta et al., unpublished data). This is the first reported example of a T-cell antigen from T. cruzi which has molecular counterparts in mammalian tissues. Structural analysis of T-cell epitopes involved in the response to this other potentially crossreactive antigen will be the object of forthcoming studies. 
